Techulon Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Out of Business

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Out of Business

Techulon General Information

Description

Developer of drugs designed to treat infectious diseases. The company's drugs are composed of novel peptide-peptide nucleic acids antimicrobial compounds using its platform, which can reveal DNA sequences in genes that are essential for the survival of microbes, enabling healthcare providers to improve patient care.

Contact Information

Website
www.techulon.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 2200 Kraft Drive
  • Suite 2475
  • Blacksburg, VA 24060
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 2200 Kraft Drive
  • Suite 2475
  • Blacksburg, VA 24060
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Techulon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 28-Feb-2022 Completed Out of Business
9. Later Stage VC 21-Aug-2020 Completed Clinical Trials - General
8. Grant 01-Sep-2019 Completed Clinical Trials - General
7. Angel (individual) 17-Jul-2019 Completed Clinical Trials - General
6. Angel (individual) 12-Oct-2017 Completed Clinical Trials - General
5. Grant 05-Aug-2013 Completed Startup
4. Later Stage VC 13-Apr-2011 Completed Startup
3. Equity Crowdfunding 13-Apr-2011 Completed Clinical Trials - General
2. Angel (individual) 28-Jul-2009 $505K $605K Completed Startup
1. Angel (individual) 22-May-2008 $100K $100K Completed Startup
To view Techulon’s complete valuation and funding history, request access »

Techulon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drugs designed to treat infectious diseases. The company's drugs are composed of novel peptide-peptide nucl
Drug Discovery
Blacksburg, VA
4 As of 2022

Basel, Switzerland
 

Parsippany, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Techulon Competitors (18)

One of Techulon’s 18 competitors is BioVersys, a Venture Capital-Backed company based in Basel, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioVersys Venture Capital-Backed Basel, Switzerland
Melinta Therapeutics Private Equity-Backed Parsippany, NJ
Prokaryotics Corporation Union, NJ
Cardurion Venture Capital-Backed Burlington, MA
Spero Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 18 competitors. Get the full list »

Techulon Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 9

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Techulon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3081534-A1 Peptide nucleic acid molecules for treatment of gram positive bacterial infection Pending 01-Nov-2017
EP-3704253-A1 Peptide nucleic acid molecules for treatment of gram positive bacterial infection Inactive 01-Nov-2017
EP-3704253-A4 Peptide nucleic acid molecules for treatment of gram positive bacterial infection Inactive 01-Nov-2017
US-20200325178-A1 Peptide nucleic acid molecules for treatment of gram positive bacterial infection Inactive 01-Nov-2017
US-20160038528-A1 Rapidly adaptable nano therapeutics for treatment of infectious disease Inactive 15-Mar-2013 A61K31/713
To view Techulon’s complete patent history, request access »

Techulon Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Techulon FAQs

  • When was Techulon founded?

    Techulon was founded in 2006.

  • Where is Techulon headquartered?

    Techulon is headquartered in Blacksburg, VA.

  • What is the size of Techulon?

    Techulon has 4 total employees.

  • What industry is Techulon in?

    Techulon’s primary industry is Drug Discovery.

  • Is Techulon a private or public company?

    Techulon is a Private company.

  • What is Techulon’s current revenue?

    The current revenue for Techulon is .

  • How much funding has Techulon raised over time?

    Techulon has raised $3.05M.

  • Who are Techulon’s competitors?

    BioVersys, Melinta Therapeutics, Prokaryotics, Cardurion, and Spero Therapeutics are some of the 18 competitors of Techulon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »